These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8184539)

  • 1. Identification of an abundant disulfide-linked complex of glycoproteins in the envelope of guinea pig cytomegalovirus.
    Britt WJ; Harrison C
    Virology; 1994 Jun; 201(2):294-302. PubMed ID: 8184539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and characterization of the guinea pig cytomegalovirus glycoprotein B gene.
    Schleiss MR
    Virology; 1994 Jul; 202(1):173-85. PubMed ID: 8009831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a major virion envelope glycoprotein complex of murine cytomegalovirus and its immunological cross-reactivity with human cytomegalovirus.
    Loh LC; Balachandran N; Qualtiere LF
    Virology; 1988 Sep; 166(1):206-16. PubMed ID: 2842945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirements for guinea pig cytomegalovirus tropism and antibody neutralization on placental amniotic sac cells.
    Choi KY; El-Hamdi NS; McGregor A
    J Gen Virol; 2020 Apr; 101(4):426-439. PubMed ID: 32068527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral Glycoprotein Complex Formation, Essential Function and Immunogenicity in the Guinea Pig Model for Cytomegalovirus.
    Coleman S; Hornig J; Maddux S; Choi KY; McGregor A
    PLoS One; 2015; 10(8):e0135567. PubMed ID: 26267274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion of the Viral Pentamer Complex in a Vaccine Design Greatly Improves Protection against Congenital Cytomegalovirus in the Guinea Pig Model.
    Choi KY; El-Hamdi NS; McGregor A
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31484753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preconception vaccination with a glycoprotein B (gB) DNA vaccine protects against cytomegalovirus (CMV) transmission in the guinea pig model of congenital CMV infection.
    Schleiss MR; Bourne N; Bernstein DI
    J Infect Dis; 2003 Dec; 188(12):1868-74. PubMed ID: 14673766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immune response to functional regions of human cytomegalovirus glycoprotein B.
    Navarro D; Lennette E; Tugizov S; Pereira L
    J Med Virol; 1997 Aug; 52(4):451-9. PubMed ID: 9260696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cytomegalovirus glycoprotein-receptor interactions.
    Rasmussen L; Resta S; Merigan T
    Transplant Proc; 1991 Jun; 23(3 Suppl 3):60-3. PubMed ID: 1648838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties.
    Akula SM; Pramod NP; Wang FZ; Chandran B
    Virology; 2001 Jun; 284(2):235-49. PubMed ID: 11384223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and composition of a family of human cytomegalovirus glycoprotein complexes designated gC-I (gB).
    Kari B; Liu YN; Goertz R; Lussenhop N; Stinski MF; Gehrz R
    J Gen Virol; 1990 Nov; 71 ( Pt 11)():2673-80. PubMed ID: 1701480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definition of a human herpesvirus-6 betaherpesvirus-specific domain in glycoprotein gH that governs interaction with glycoprotein gL: substitution of human cytomegalovirus glycoproteins permits group-specific complex formation.
    Anderson RA; Liu DX; Gompels UA
    Virology; 1996 Mar; 217(2):517-26. PubMed ID: 8610443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure, composition and heparin binding properties of a human cytomegalovirus glycoprotein complex designated gC-II.
    Kari B; Gehrz R
    J Gen Virol; 1993 Feb; 74 ( Pt 2)():255-64. PubMed ID: 8381465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus.
    Britt WJ; Auger D
    J Virol; 1986 Apr; 58(1):185-91. PubMed ID: 3005648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and expression of the guinea pig cytomegalovirus glycoprotein B (gB) in a recombinant baculovirus: utility for vaccine studies for the prevention of experimental infection.
    Schleiss MR; Jensen NJ
    J Virol Methods; 2003 Mar; 108(1):59-65. PubMed ID: 12565154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycoprotein H-related complexes of human cytomegalovirus: identification of a third protein in the gCIII complex.
    Li L; Nelson JA; Britt WJ
    J Virol; 1997 Apr; 71(4):3090-7. PubMed ID: 9060671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convalescent Immunity to Guinea Pig Cytomegalovirus Induces Limited Cross Strain Protection against Re-Infection but High-Level Protection against Congenital Disease.
    Choi KY; El-Hamdi NS; McGregor A
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and processing of the major envelope glycoprotein of murine cytomegalovirus.
    Loh LC
    Virology; 1991 Jan; 180(1):239-50. PubMed ID: 1845824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA vaccines expressing glycoprotein complex II antigens gM and gN elicited neutralizing antibodies against multiple human cytomegalovirus (HCMV) isolates.
    Shen S; Wang S; Britt WJ; Lu S
    Vaccine; 2007 Apr; 25(17):3319-27. PubMed ID: 17287056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of the guinea-pig cytomegalovirus glycoprotein H gene.
    Brady RC; Schleiss MR
    Arch Virol; 1996; 141(12):2409-24. PubMed ID: 9526546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.